![Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-021-00570-x/MediaObjects/41575_2021_570_Fig1_HTML.png)
Vaccination at the forefront of the fight against hepatitis B and C | Nature Reviews Gastroenterology & Hepatology
![Individual immune responses to a challenge dose of hepatitis A or/and... | Download Scientific Diagram Individual immune responses to a challenge dose of hepatitis A or/and... | Download Scientific Diagram](https://www.researchgate.net/publication/314651177/figure/tbl1/AS:669016997756939@1536517490370/Individual-immune-responses-to-a-challenge-dose-of-hepatitis-A-or-and-hepatitis-B-vaccine.png)
Individual immune responses to a challenge dose of hepatitis A or/and... | Download Scientific Diagram
![CDC on X: "Hepatitis B birth dose vaccine, given w/in 24 hours of life, prevents mother-to-child transmission of #hepB virus, a leading cause of liver disease & death. New @CDCMMWR on hep CDC on X: "Hepatitis B birth dose vaccine, given w/in 24 hours of life, prevents mother-to-child transmission of #hepB virus, a leading cause of liver disease & death. New @CDCMMWR on hep](https://pbs.twimg.com/media/F1gLCxhWAAMxFxb.jpg)
CDC on X: "Hepatitis B birth dose vaccine, given w/in 24 hours of life, prevents mother-to-child transmission of #hepB virus, a leading cause of liver disease & death. New @CDCMMWR on hep
![Missed hepatitis B birth dose vaccine is a risk factor for incomplete vaccination at 18 and 24 months - ScienceDirect Missed hepatitis B birth dose vaccine is a risk factor for incomplete vaccination at 18 and 24 months - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0163445318302871-fx1.jpg)
Missed hepatitis B birth dose vaccine is a risk factor for incomplete vaccination at 18 and 24 months - ScienceDirect
![Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X19310448-ga1.jpg)